Catalyst Funds Management Pty LTD Insmed Inc Transaction History
Catalyst Funds Management Pty LTD
- $455 Billion
- Q3 2024
A detailed history of Catalyst Funds Management Pty LTD transactions in Insmed Inc stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 7,000 shares of INSM stock, worth $494,199. This represents 0.11% of its overall portfolio holdings.
Number of Shares
7,000Holding current value
$494,199% of portfolio
0.11%Shares
1 transactions
Others Institutions Holding INSM
# of Institutions
462Shares Held
181MCall Options Held
2.07MPut Options Held
2.28M-
Vanguard Group Inc Valley Forge, PA17.1MShares$1.21 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.01 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.6MShares$888 Million0.11% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y910.5MShares$741 Million62.32% of portfolio
-
Capital International Investors Los Angeles, CA6.52MShares$461 Million0.09% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $9.56B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...